Fundraising Fox
🦊/People
Sign in

Thomas Needham

Investor

Investor at Broadview Ventures · Board director at Basking Biosciences · Director at Renovacor

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Thomas

524 people in our graph share verified history with Thomas — schools, employers, funds. One of them is your warm intro.

Ulrik B. NielsenunlockedThomas: together at Merrimack (2017–2018)
×2Thomas: together at Bowdoin College
Thomas: together at Comanche Biopharma
×4Thomas: together at Advent International

About

Managing Director leading Broadview's Biopharmaceuticals practice and overseeing investment strategy and portfolio management; also Managing Director of Longview Ventures. Brings 30 years in life-science venture investing and executive roles, previously at Merrimack, C4 Therapeutics, Synthesis Capital, and Advent International.

Contact· self-published, not guessed

Likely email· guessed from name + firm domain, not firm-published

Board director at Basking Biosciences

Intro paths

→

In turn, Thomas can intro founders to Basking Biosciences's investors below.

Basking Biosciences's investors · 6

ARCH Venture PartnersChicago · $50K – $250M checks · since 2025Broadview VenturesBoston · since 2020Insight PartnersNew York · $120M – $350M checks · since 2020Rev1 VenturesColumbus · since 2024RTW Investments L.P.New York · since 2024Solas BioVenturesChattanooga · since 2020

Co-founders at Basking Biosciences

SNShahid Nimjee
Shahid NimjeeCo-founder, Chief Scientific Officer and Stroke Clinical Lead
BS
Bruce SullengerCo-founder

Director at Renovacor

Intro paths

→

In turn, Thomas can intro founders to Renovacor's investors below.

Renovacor's investors · 6

BioAdvanceConshohocken · $500K – $1.5M checksBroadview VenturesBostonElysia CapitalTurinInnogest CapitalMilanNew Leaf Venture PartnersNew YorkNovartis Venture FundBasel · $5M – $25M checks

Experience

  1. Broadview Ventures IncManaging Directorcurrent2026 — presentBoston, MA
  2. Broadview Ventures IncDirector, Head of BioPharma2018 — 2026Boston, MA
  3. Longview VenturesManaging Directorcurrent2025 — presentBoston, MA
  4. Longview VenturesDirector, Head of BioPharma2019 — 2025
  5. Mosanna TherapeuticsBoard Observercurrent2025 — present
  6. Alveron PharmaBoard Observercurrent2024 — present
  7. Isomab LtdBoard of Directors, Membercurrent2024 — presentNottingham, England
  8. Basking Biosciences IncBoard of Directors, Membercurrent2023 — present
  9. Basking Biosciences IncChairman, Board of Directors2020 — 2023
  10. Comanche BiopharmaBoard Observercurrent2021 — presentConcord, MA
  11. HAYA TherapeuticsBoard Observercurrent2020 — presentLausanne, Vaud, Switzerland
  12. Antag TherapeuticsBoard Observer2023 — 2024Copenagen, Denmark
  13. Antag TherapeuticsBoard of Directors, Member2020 — 2023Copenhagen, Denmark
  14. RenovacorBoard of Directors, Member2021 — 2022Philadelphia, PA
  15. RenovacorChairman, Board of Directors2019 — 2021Philadelphia, PA
  16. Kantum BioBoard of Directors, Member2021 — 2022Boston, MA
  17. Kantum BioBoard Observer2018 — 2021Boston, MA
  18. NIDOBoard Observer2018 — 2019Needham, MA
  19. MerrimackChief Business Officer2017 — 2018Greater Boston
  20. C4 Therapeutics, Inc.Senior Vice President, Business Development2016 — 2017Greater Boston
  21. Synthesis CapitalManaging Director2007 — 2016Greater Boston
  22. Advent InternationalPrincipal2002 — 2007Greater Boston
  23. GPC BiotechVice President, Business Development2000 — 2002
  24. Mitotix, Inc.Vice President, Business Development1994 — 2000

Skills & more

Management3Strategy3Strategic Planning2Business Development13Corporate Development3Lifesciences7Biotechnology17Angel Investing1M&A experience1Healthcare3Acquisition Integration1Venture Capital26
+12 moreClinical DevelopmentCorporate FinanceMergers & AcquisitionsBiopharmaceuticalsLicensingDue DiligenceTechnology TransferAsset ManagmentCommercializationDrug DiscoveryBusiness StrategyPharmaceutical Industry

From Thomas's professional profile.

Investments

Investor

Isomab

Per curated public sources.

Colleagues at Broadview Ventures

Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures
David Prim
Principal at Broadview Ventures

Network5

Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Prim
Principal at Broadview Ventures
Maria Berkman
Partner at Vensana Capital

Investors connected to Thomas in public investor directories — a warm-intro map.

Frequently asked questions

Who is Thomas Needham?
Managing Director leading Broadview's Biopharmaceuticals practice and overseeing investment strategy and portfolio management; also Managing Director of Longview Ventures. Brings 30 years in life-science venture investing and executive roles, previously at Merrimack, C4 Therapeutics, Synthesis Capital, and Advent International.
Where does Thomas Needham work?
Thomas Needham is Investor at Broadview Ventures and Board director at Basking Biosciences.
What check size does Thomas Needham write?
Thomas Needham typically writes checks of $100K – $5M.
What companies has Thomas Needham invested in?
Investments tracked here include Isomab.
Where did Thomas Needham go to school?
Thomas Needham studied at Babson F.W. Olin Graduate School of Business (MBA, Highest Distinction); Bowdoin College (AB, cum laude).

Same school

Shared employers